跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22 条关于
“CalRx”
全部
22
临床试验
10
药物
4
机构
0
资讯
8
去年
California's State-Branded Insulin Program Faces Significant Delays, No Clear Launch Timeline
11个月前
California Launches First State-Branded Insulin Program, Offering $55 Five-Pack to Combat High Drug Costs
8个月前
CivicaScript Launches Low-Cost Insulin Biosimilar and Ustekinumab Alternative in US Market
11个月前
Biocon Biologics and Civica Expand Partnership to Launch Private-Label Insulin Glargine in US Market
2个月前
CivicaScript's Nonprofit Model Delivers $16 Million in Generic Drug Savings in 2025, Cumulative Savings Reach $44 Million
去年
Drug Shortages Crisis: Causes, Impacts, and Solutions in the US Healthcare System
上个月
CAR T Cell Therapy Targets CALR Mutation Driving Rare Blood Cancers
去年
Incyte's INCA033989 Shows 86% Response Rate in CALR-Mutant Blood Cancer Trial